Mirae Asset Global Etfs Holdings Ltd. Wave Life Sciences Ltd. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 37,421 shares of WVE stock, worth $615,201. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,421Holding current value
$615,201% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding WVE
# of Institutions
148Shares Held
93.8MCall Options Held
33KPut Options Held
57.2K-
Ra Capital Management, L.P. Boston, MA18.2MShares$299 Million1.37% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx7.67MShares$126 Million0.75% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$111 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$101 Million35.47% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.36MShares$88.1 Million0.05% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $1.43B
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...